HIGH-PURITY LEVOTHYROXINE IMPURITY STANDARDS FOR PHARMACEUTICAL USE

Levothyroxine impurities can form during API synthesis and formulation due to degradation reactions, such as oxidation, hydrolysis, or halogenation, which occur under specific conditions like temperature, pH, or exposure to light. These impurities may arise from incomplete reactions or the interaction of the active ingredient with excipients durin